A Study of Almonertinib With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer
Latest Information Update: 30 Nov 2022
Price :
$35 *
At a glance
- Drugs Aumolertinib (Primary) ; Carboplatin; Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Dec 2020 New trial record